Total Payments
$15,301
2024 Payments
$1,671
Companies
51
Transactions
1,025
Medicare Patients
11,652
Medicare Billing
$407,622
Payment Breakdown by Category
Food & Beverage$15,271 (99.8%)
Education$29.50 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,271 | 1,020 | 99.8% |
| Education | $29.50 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,138 | 138 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,249 | 86 | $0 (2024) |
| PFIZER INC. | $1,136 | 81 | $0 (2024) |
| ABBVIE INC. | $1,023 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $901.87 | 42 | $0 (2024) |
| Amgen Inc. | $852.27 | 62 | $0 (2023) |
| Lilly USA, LLC | $822.90 | 59 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $803.27 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $725.13 | 42 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $669.54 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,671 | 89 | Novo Nordisk Inc ($257.51) |
| 2023 | $2,015 | 120 | ABBVIE INC. ($321.00) |
| 2022 | $2,083 | 134 | Novo Nordisk Inc ($335.47) |
| 2021 | $2,571 | 174 | AbbVie Inc. ($336.22) |
| 2020 | $1,689 | 126 | Allergan, Inc. ($223.97) |
| 2019 | $1,765 | 135 | Novo Nordisk Inc ($380.77) |
| 2018 | $1,646 | 107 | Novo Nordisk Inc ($250.14) |
| 2017 | $1,861 | 140 | Novo Nordisk Inc ($227.59) |
All Payment Transactions
1,025 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: UROLOGY | ||||||
| 11/21/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $131.94 | General |
| Category: Coronary | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: Medical Device | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.62 | General |
| Category: Medical Device | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,815 | 4,808 | $304,493 | $106,950 |
| 2022 | 35 | 2,622 | 4,441 | $273,829 | $95,455 |
| 2021 | 38 | 2,958 | 5,173 | $289,225 | $107,278 |
| 2020 | 40 | 3,257 | 5,623 | $293,170 | $97,940 |
Total Patients
11,652
Total Services
20,045
Medicare Billing
$407,622
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 535 | $123,050 | $38,370 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 127 | 127 | $41,910 | $14,587 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 184 | $29,072 | $9,459 | 32.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 193 | 301 | $12,040 | $4,954 | 41.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 221 | 363 | $11,616 | $4,562 | 39.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 224 | 380 | $7,980 | $3,884 | 48.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 235 | 448 | $5,944 | $3,516 | 59.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $4,080 | $3,237 | 79.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 228 | 417 | $7,923 | $3,132 | 39.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 102 | 102 | $4,794 | $2,872 | 59.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 24 | 24 | $9,048 | $2,827 | 31.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 128 | 128 | $6,400 | $2,071 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 201 | $11,658 | $1,906 | 16.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 52 | 56 | $3,864 | $1,513 | 39.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 88 | 102 | $3,672 | $1,465 | 39.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 95 | 147 | $3,381 | $1,308 | 38.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 60 | 60 | $1,860 | $1,226 | 65.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 59 | 70 | $3,010 | $1,207 | 40.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 20 | 22 | $1,958 | $1,006 | 51.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 23 | 23 | $2,645 | $796.53 | 30.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 37 | 37 | $1,591 | $700.04 | 44.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 76 | 85 | $1,700 | $492.60 | 29.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 39 | 52 | $1,092 | $447.41 | 41.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 76 | 85 | $1,105 | $410.44 | 37.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 34 | 41 | $697.00 | $331.60 | 47.6% |
About Dr. Wesley Payne, M.D
Dr. Wesley Payne, M.D is a Family Medicine healthcare provider based in Seymour, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053415455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wesley Payne, M.D has received a total of $15,301 in payments from pharmaceutical and medical device companies, with $1,671 received in 2024. These payments were reported across 1,025 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($15,271).
As a Medicare-enrolled provider, Payne has provided services to 11,652 Medicare beneficiaries, totaling 20,045 services with total Medicare billing of $407,622. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Seymour, TN
- Active Since 09/07/2006
- Last Updated 01/18/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053415455
Products in Payments
- Ozempic (Drug) $1,058
- ELIQUIS (Drug) $882.35
- TRELEGY ELLIPTA (Drug) $785.84
- VRAYLAR (Drug) $784.92
- JARDIANCE (Drug) $678.17
- FARXIGA (Drug) $651.37
- XARELTO (Drug) $552.14
- UBRELVY (Drug) $349.38
- XIFAXAN (Drug) $349.30
- Vascepa (Drug) $348.30
- CHANTIX (Drug) $341.21
- Kerendia (Drug) $336.57
- NURTEC ODT (Drug) $336.27
- JANUVIA (Drug) $312.56
- TRULICITY (Drug) $280.48
- ENTRESTO (Drug) $241.37
- TRINTELLIX (Drug) $235.81
- EVENITY (Biological) $228.35
- Victoza (Drug) $223.89
- Rybelsus (Drug) $222.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Seymour
Garrett Rowe, Md, MD
Family Medicine — Payments: $8,632
Family Medicine $8,632
Dr. Bradley Morin, M.d, M.D
Family Medicine — Payments: $8,001
Family Medicine $8,001
Dr. Nicholas Lemming, Md, MD
Family Medicine — Payments: $7,667
Family Medicine $7,667
Dr. David Hartung, Do, DO
Family Medicine — Payments: $7,097
Family Medicine $7,097
Wayne Stuart, Do, DO
Family Medicine — Payments: $7,051
Family Medicine $7,051
Clay Stalcup, Md, MD
Family Medicine — Payments: $5,768
Family Medicine $5,768